- The Client Expertise Affiliation (CTA) awards Abbott a number of CES 2023 Innovation Awards for industry-leading well being applied sciences
- Abbott’s Aveir™ single-chamber (VR) leadless pacemaker, Proclaim™ Plus SCS system, Alinity® m Monkeypox PCR check honored
- Different current Abbott innovation honors embody Abbott’s FreeStyle Libre® know-how named the perfect medical know-how within the final 50 years by the Galien Basis
ABBOTT PARK, Sick., Nov. 17, 2022 /PRNewswire/ — Abbott (NYSE: ABT) has been acknowledged by the Client Expertise Affiliation (CTA) with three CES 2023 Innovation Awards for its life-changing applied sciences which are advancing the well being tech {industry} and bettering the lives of individuals worldwide. The CTA is the group behind the Client Electronics Present (CES), probably the most influential know-how occasion on the earth.
Forward of the CES 2023 occasion, three of Abbott’s industry-leading tech developments received CES 2023 Innovation Awards, all inside the Digital Well being award class:
- Aveir VR Leadless Pacemaker – The world’s solely leadless pacemaker with a singular mapping functionality to evaluate appropriate positioning previous to placement and designed to be utterly retrievable. The system was developed by Abbott to deal with sufferers with sluggish coronary heart rhythms and eliminates wires used to ship remedy in conventional pacemakers.
- Proclaim Plus SCS System – Abbott’s newest development in neurostimulation remedy to deal with power ache utilizing low doses of focused BurstDR™ stimulation that may be adjusted as an individual’s therapeutic wants evolve throughout as much as six areas of the physique, which is extra ache websites within the physique than ever earlier than.
- Alinity m Monkeypox PCR check1 – A primary of its sort, Abbott acquired FDA Emergency Use Authorization of its PCR check for detecting the monkeypox virus.
The CES Innovation Awards program is an annual competitors honoring excellent design and engineering in client know-how merchandise. This system acknowledges the 12 months’s most modern merchandise in a large number of client know-how product classes and distinguishes the highest-rated in every.
Final 12 months, Abbott turned the first-ever healthcare firm to keynote CES, and the corporate has acquired 9 CES Innovation Awards previously two years.
Different Abbott merchandise beforehand honored with CES Innovation Awards embody FreeStyle Libre 32, the world’s smallest, thinnest3 and most correct4 14-day glucose sensor and a CES 2022 Better of Innovation Award winner; BinaxNOW™5, the #1 COVID-19 self check within the U.S.; and the UltreonTM 1.0 intravascular imaging and coronary physiology software program platform, which helps information and optimize stenting choices, combining optical coherence tomography with synthetic intelligence.
Along with the CES 2023 awards, Abbott additionally was not too long ago acknowledged with different prime honors for its healthcare know-how together with its revolutionary FreeStyle Libre know-how being named the perfect medical know-how within the final 50 years by the Galien Basis. The FreeStyle Libre portfolio has reworked the lives of roughly 4.5 million folks6 dwelling with diabetes globally.
About Abbott
Abbott is a worldwide healthcare chief that helps folks reside extra totally in any respect phases of life. Our portfolio of life-changing applied sciences spans the spectrum of healthcare, with main companies and merchandise in diagnostics, medical gadgets, nutritionals and branded generic medicines. Our 113,000 colleagues serve folks in additional than 160 nations.
Join with us at www.abbott.com, on LinkedIn at www.linkedin.com/firm/abbott-/, on Fb at www.fb.com/Abbott and on Twitter @AbbottNews.
1 This product has not been FDA cleared or authorised, however has been licensed for emergency use by FDA underneath an EUA to be used by the licensed laboratories; This product has been licensed just for the detection of nucleic acid from monkeypox virus, not for every other viruses or pathogens; The emergency use of this product is simply licensed all through the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or prognosis of an infection with the monkeypox virus, together with in vitro diagnostics that detect and/or diagnose an infection with non-variola Orthopoxvirus, underneath Part 564(b)(1) of the Federal Meals, Drug, and Beauty Act, 21 U.S.C. § 360bbb-3(b)(1), until the declaration is terminated or authorization is revoked sooner.
2 Indications and Essential Security Data: FreeStyle Libre 3 system: Failure to make use of the FreeStyle Libre 3 system as instructed in labeling might lead to lacking a extreme low or excessive glucose occasion and/or making a remedy determination, leading to damage. If glucose alarms and readings don’t match signs or expectations, use a fingerstick worth from a blood glucose meter for remedy choices. Search medical consideration when acceptable or contact Abbott at 855-632-8658 or FreeStyleLibre.us for security information.
3 Amongst patient-applied sensors.
4 Knowledge on file, Abbott Diabetes Care. Comparability based mostly on publicly obtainable data.
5 The BinaxNOW™ COVID-19 Antigen Self Check is a lateral movement immunoassay supposed for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from people with or with out signs or different epidemiological causes to suspect COVID-19 an infection when examined twice over three days with a minimum of 24 hours (and not more than 48 hours) between exams. This check is allowed for non-prescription dwelling use with self-collected direct anterior nasal (nares) swab samples from people aged 15 years or older or grownup collected anterior nasal (nares) swab samples from people aged two years or older.
The BinaxNOW™ COVID-19 exams haven’t been FDA cleared or authorised. They’ve been licensed by the FDA underneath an emergency use authorization. They’ve been licensed just for the detection of proteins from SARS-CoV-2, not for every other viruses or pathogens, and are solely licensed all through the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or prognosis of COVID-19 underneath Part 564(b)(1) of the Federal Meals, Drug and Beauty Act, 21 U.S.C. § 360bbb-3(b)(1), until the declaration is terminated or authorization is revoked sooner. For serial testing, the BinaxNOW COVID-19 Antigen Checks needs to be carried out twice over 3 days, a minimum of 24 hours (and not more than 48 hours) aside. For symptomatic use, a single check can be utilized.
6 Knowledge on file, Abbott Diabetes Care. Knowledge based mostly on the variety of customers worldwide for the FreeStyle Libre portfolio in comparison with the variety of customers for different main private use, sensor-based glucose monitoring programs.
SOURCE Abbott
